• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种在中枢神经系统中与腺苷酸环化酶正性偶联的非经典5-羟色胺受体。

A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.

作者信息

Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J

机构信息

Centre CNRS-INSERM de Pharmacologie Endocrinologie, Montpellier, France.

出版信息

Mol Pharmacol. 1988 Dec;34(6):880-7.

PMID:2849052
Abstract

A nonclassical 5-hydroxytryptamine (5-HT) receptor mediates the stimulation of adenylate cyclase activity in mouse embryo colliculi neurons in primary culture. The pharmacological profile characterized with agonists and antagonists suggests that this 5-HT receptor does not appear to correspond to a known 5-HT receptor. On this 5-HT receptor, 5-HT (EC50 = 109 +/- 17 nM) and 5-methoxytryptamine (5-MeOT) were equipotent agonists. The other tryptamine derivatives, 5-carboxamidotryptamine (5-CT) and 5-methoxy-N,N-dimethyltryptamine (5-MeOT-N,N-DMT), were full potent agonists, whereas tryptamine, bufotenine, and 2-CH3-5-HT were weak partial agonists. Two selective 5-HT1A agonists: 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) and ipsapirone, could not stimulate adenylate cyclase. RU 24969, a tetrahydropyridoindole derivative that is a potent 5-HT1A and 5-HT1B agonist was also inactive, whereas RU 28253, another member of this series, could stimulate cAMP production. The action of antagonists acting on 5-HT1 or 5-HT2 receptors, such as methiothepin (5-HT1 and 5-HT2), metergoline (5-HT1 and 5-HT2), spiperone (5-HT1A and 5-HT2), (-)-pindolol (5-HT1B), mesulergine (5-HT1C), and ketanserin (5-HT2), were almost inactive in reversing the 5-HT stimulating effect. The selective 5-HT3 antagonist ICS 205 930 was a full competitive antagonist at this receptor. Nevertheless, MDL 72222, which is also a 5-HT3 antagonist, was very weak in antagonizing the 5-HT stimulatory effect. A receptor with similar characteristics has also been found in guinea pig hippocampal membranes. In these membranes, the second receptor of low affinity for 5-HT, termed RL, which is positively coupled to adenylate cyclase, was also antagonized by ICS 205 930. The relatively low affinity of this hippocampal receptor for 5-CT, its stimulation by RU 28253 but not by RU 24969, and its previously reported pharmacological characteristics support the contention that this 5-HT receptor and the 5-HT receptor of mouse embryo colliculi neurons in primary culture (both positively coupled to cAMP formation) present great homologies. Inasmuch as none of the classical specific 5-HT1 and 5-HT2 agonists or antagonists interact with these 5-HT receptors, it is unlikely that they belong to 5-HT1 or 5-HT2 receptor categories.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

一种非经典的5-羟色胺(5-HT)受体介导了原代培养的小鼠胚胎丘脑中腺苷酸环化酶活性的刺激。用激动剂和拮抗剂表征的药理学特征表明,这种5-HT受体似乎与已知的5-HT受体不对应。在这种5-HT受体上,5-HT(EC50 = 109 +/- 17 nM)和5-甲氧基色胺(5-MeOT)是等效激动剂。其他色胺衍生物,5-羧酰胺色胺(5-CT)和5-甲氧基-N,N-二甲基色胺(5-MeOT-N,N-DMT)是完全有效的激动剂,而色胺、蟾蜍色胺和2-CH3-5-HT是弱部分激动剂。两种选择性5-HT1A激动剂:8-羟基-2-(二正丙基氨基)-四氢萘(8-OH-DPAT)和ipsapirone,不能刺激腺苷酸环化酶。RU 24969,一种四氢吡啶并吲哚衍生物,是一种有效的5-HT1A和5-HT1B激动剂,也没有活性,而该系列的另一个成员RU 28253可以刺激cAMP的产生。作用于5-HT1或5-HT2受体的拮抗剂,如甲硫哒嗪(5-HT1和5-HT2)、麦角苄酯(5-HT1和5-HT2)、螺哌隆(5-HT1A和5-HT2)、(-)-吲哚洛尔(5-HT1B)、美舒麦角(5-HT1C)和酮色林(5-HT2),在逆转5-HT刺激作用方面几乎没有活性。选择性5-HT3拮抗剂ICS 205 930是该受体的完全竞争性拮抗剂。然而,同样是5-HT3拮抗剂的MDL 72222在拮抗5-HT刺激作用方面非常弱。在豚鼠海马膜中也发现了具有类似特征的受体。在这些膜中,对5-HT低亲和力的第二种受体,称为RL,它与腺苷酸环化酶正偶联,也被ICS 205 930拮抗。这种海马受体对

相似文献

1
A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.一种在中枢神经系统中与腺苷酸环化酶正性偶联的非经典5-羟色胺受体。
Mol Pharmacol. 1988 Dec;34(6):880-7.
2
Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.5-羟色胺-1A受体的药理学,其可抑制原代培养海马体和皮层神经元中cAMP的产生。
Mol Pharmacol. 1988 Feb;33(2):178-86.
3
8-hydroxy-2-(di-n-propylamino)tetralin-responsive 5-hydroxytryptamine4-like receptor expressed in bovine pulmonary artery smooth muscle cells.在牛肺动脉平滑肌细胞中表达的对8-羟基-2-(二正丙基氨基)四氢萘有反应的5-羟色胺4样受体
Mol Pharmacol. 1992 Nov;42(5):817-25.
4
5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.5-羟色胺(5-HT)1A受体与甩尾反应。I. 8-羟基-2-(二正丙基氨基)四氢萘溴化氢诱导大鼠自发甩尾作为5-HT1A受体介导活性的体内模型。
J Pharmacol Exp Ther. 1991 Mar;256(3):973-82.
5
Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes.豚鼠海马膜中与腺苷酸环化酶偶联的两种5-羟色胺受体的药理学特性
Mol Pharmacol. 1987 Apr;31(4):357-67.
6
Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.激活腺苷酸环化酶的哺乳动物血清素受体的分子克隆
Mol Pharmacol. 1993 Aug;44(2):229-36.
7
Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.大鼠海马膜中与腺苷酸环化酶活性负偶联的突触后5-羟色胺1A受体缺乏明显的受体储备。
Mol Pharmacol. 1992 Jun;41(6):1066-72.
8
Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.氨甲基色满衍生物BAY x 3702作为高效5-羟色胺1A受体激动剂的特性研究。
J Pharmacol Exp Ther. 1998 Mar;284(3):1082-94.
9
Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.血清素(5-羟色胺,5-HT)受体激动剂、部分激动剂及拮抗剂在永久转染的HeLa细胞中对与腺苷酸环化酶负性偶联的克隆人5-HT1A受体的活性。
Biochem Pharmacol. 1993 Jan 26;45(2):375-83. doi: 10.1016/0006-2952(93)90073-6.
10
Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.5-羟色胺1A受体对5-羟色胺2受体介导的速激肽诱导的大鼠气管体外收缩的调节作用
Br J Pharmacol. 1998 Apr;123(8):1571-8. doi: 10.1038/sj.bjp.0701771.

引用本文的文献

1
Investigation of neuromodulation of the endbulb of Held synapse in the cochlear nucleus by serotonin and norepinephrine.血清素和去甲肾上腺素对耳蜗核中 Held 终球突触神经调节的研究。
Front Cell Neurosci. 2025 Apr 28;19:1575158. doi: 10.3389/fncel.2025.1575158. eCollection 2025.
2
Serotonin receptor-mediated vasorelaxation occurs primarily through 5-HT activation in bovine lateral saphenous vein.5-羟色胺受体介导的血管舒张主要通过牛外侧隐静脉中 5-HT 的激活发生。
Physiol Rep. 2024 Jul;12(13):e16128. doi: 10.14814/phy2.16128.
3
The Serotonin 4 Receptor Subtype: A Target of Particular Interest, Especially for Brain Disorders.
5-羟色胺 4 受体亚型:一个特别引人关注的靶点,尤其是针对脑部疾病。
Int J Mol Sci. 2024 May 11;25(10):5245. doi: 10.3390/ijms25105245.
4
Serotonin Receptors in Myocardial Infarction: Friend or Foe?心肌梗死中的 5-羟色胺受体:是敌是友?
ACS Chem Neurosci. 2024 Apr 17;15(8):1619-1634. doi: 10.1021/acschemneuro.4c00031. Epub 2024 Apr 4.
5
Radiotracers for the Central Serotoninergic System.中枢5-羟色胺能系统的放射性示踪剂
Pharmaceuticals (Basel). 2022 May 3;15(5):571. doi: 10.3390/ph15050571.
6
Astroglial Serotonin Receptors as the Central Target of Classic Antidepressants.星形胶质细胞 5-羟色胺受体作为经典抗抑郁药的中枢靶点。
Adv Neurobiol. 2021;26:317-347. doi: 10.1007/978-3-030-77375-5_13.
7
Memory Disorders Related to Hippocampal Function: The Interest of 5-HTRs Targeting.与海马功能相关的记忆障碍:5-HT 受体靶向的作用。
Int J Mol Sci. 2021 Nov 8;22(21):12082. doi: 10.3390/ijms222112082.
8
5-HT Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression.5-HT 受体不参与氟西汀在皮质酮抑郁模型中的作用。
ACS Chem Neurosci. 2021 Jun 2;12(11):2036-2044. doi: 10.1021/acschemneuro.1c00158. Epub 2021 May 11.
9
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.国际基础和临床药理学联合会。CX. 5-羟色胺受体分类:药理学与功能。
Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552.
10
Translating the promise of 5HT receptor agonists for the treatment of depression.将 5HT 受体激动剂治疗抑郁症的前景变为现实。
Psychol Med. 2021 May;51(7):1111-1120. doi: 10.1017/S0033291720000604. Epub 2020 Apr 3.